Concordance of intrinsic subtyping using data from Prosigna® and research-based RNA-sequencing of tissue in Triple Negative Breast Cancer Trial (TNT)

被引：0
|
作者：
Tovey, Holly [1 ]
Parker, Joel [2 ]
Hoadley, Katherine [2 ]
Kernaghan, Sarah [1 ]
Gazinska, Patrycja [3 ]
Pinder, Sarah [4 ]
Ben Haynes [5 ]
Sidhu, Kally [5 ]
Bliss, Judith [1 ]
Perou, Charles M. [2 ]
Tutt, Andrew [3 ]
Grigoriadis, Anita [6 ]
Cheang, Maggie C. U. [1 ]
机构：
[1] Inst Canc Res, Clin Trials & Stat Unit, London, England
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London, England
[4] Kings Coll London, Kings Hlth Partners Canc Biobank, London, England
[5] Royal Marsden Hosp, Ralph Lauren Ctr Breast Canc Res, London, England
[6] Kings Coll London, Guys Hosp, Breast Canc Now Res Unit, Ctr Canc, London, England
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2020年 / 180卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：553 / 553
页数：1
相关论文
共 14 条
  • [1] Concordance of intrinsic subtyping and risk of recurrence (ROR) scores between matched primary and metastatic tissue from Triple Negative Breast Cancer Trial (TNT)
    Cheang, Maggie Chon U.
    Bliss, Judith
    Dowsett, Mitch
    Kilburn, Lucy
    Grigoriadis, Anita
    Gillett, Cheryl
    Pinder, Sarah
    Gazinska, Patrycja
    Haynes, Ben
    Kernaghan, Sarah
    Tovey, Holly
    Owen, Julie
    Harries, Mark
    Ellis, Paul Anthony
    Nicholas, Andrew
    Tutt, James
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Molecular classification of triple negative breast cancer via RNA-sequencing data
    Thompson, Kevin J.
    Tang, Xiaojia
    Sun, Zhifu
    Sinnwell, Jason P.
    Sicotte, Hugues
    Mahoney, Douglas W.
    Hart, Steven
    Vedell, Peter T.
    Barman, Poulami
    Passow, Jeanette E. Eckel
    Wieben, Eric D.
    Ingle, James N.
    Boughey, Judy C.
    Wang, Liewei
    Weinshilboum, Richard
    Kalari, Krishna R.
    Goetz, Matthew P.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Biomarker discovery in triple negative breast cancer using RNA-sequencing analysis
    Poulsen, Jenna B.
    Dobbs, Mauri E.
    Rapier-Sharman, Naomi
    Pickett, Brett E.
    CANCER RESEARCH, 2023, 83 (07)
  • [4] Identifying treatment options for triple negative breast cancer patients using RNA-sequencing
    Pedersen, Gitte
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [5] Prognosis Prediction Through an Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Data in Triple-Negative Breast Cancer
    Wang, Xiangru
    Chen, Hanghang
    FRONTIERS IN GENETICS, 2022, 13
  • [6] RNA-sequencing and microarray data mining revealing: the aberrantly expressed mRNAs were related with a poor outcome in the triple negative breast cancer patients
    Fei, Hongjun
    Chen, Songchang
    Xu, Chenming
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [7] Analysis of single-cell RNA-sequencing data identifies a hypoxic tumor subpopulation associated with poor prognosis in triple-negative breast cancer
    Shi, Yi
    Huang, Xiaoqian
    Du, Zhaolan
    Tan, Jianjun
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2022, 19 (06) : 5793 - 5812
  • [8] Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
    Jovanovic, Bojana
    Sheng, Quanhu
    Seitz, Robert S.
    Lawrence, Kasey D.
    Morris, Stephan W.
    Thomas, Lance R.
    Hout, David R.
    Schweitzer, Brock L.
    Guo, Yan
    Pietenpol, Jennifer A.
    Lehmann, Brian D.
    BMC CANCER, 2017, 17
  • [9] Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue
    Bojana Jovanović
    Quanhu Sheng
    Robert S. Seitz
    Kasey D. Lawrence
    Stephan W. Morris
    Lance R. Thomas
    David R. Hout
    Brock L. Schweitzer
    Yan Guo
    Jennifer A. Pietenpol
    Brian D. Lehmann
    BMC Cancer, 17
  • [10] RNA-sequencing of residual triple-negative breast cancers after neoadjuvant chemotherapy compared to matched pretreatment biopsies from the Hoosier Oncology Group trial BRE09-146.
    Radovich, Milan
    Hancock, Bradley Allen
    Solzak, Jeffrey Peter
    Atale, Rutuja
    Badve, Sunil S.
    Miller, Kathy D.
    Schneider, Bryan Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12